Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 2/20 | 0.57 |
| ▸ | PPARA | Q07869 | 2/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | FTH1 | P02794 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.32 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.30 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25216100 | 0.85 | CNR2 (0.53) | CNR2PPARAMEN1KMT2ACYP3A4 | |
| Beta-Caryophyllene SCHEMBL4195140 | 0.73 | CNR2 (1.00) | CNR2PPARAMEN1KMT2ACYP3A4 | |
| Caryophyllene SCHEMBL4355327 | 0.73 | CNR2 (1.00) | CNR2PPARAMEN1KMT2ACYP3A4 | |
| Beta-Caryophyllene SCHEMBL4195149 | 0.73 | CNR2 (1.00) | CNR2PPARAMEN1KMT2ACYP3A4 | |
| Beta-Caryophyllene SCHEMBL1866747 | 0.73 | CNR2 (1.00) | CNR2PPARAMEN1KMT2ACYP3A4 | |
| Caryophyllene SCHEMBL310637 | 0.73 | CNR2 (1.00) | CNR2PPARAMEN1KMT2ACYP3A4 | |
| Beta-Caryophyllene SCHEMBL113830 | 0.73 | CNR2 (1.00) | CNR2PPARAMEN1KMT2ACYP3A4 | |
| Beta-Caryophyllene SCHEMBL24774027 | 0.73 | CNR2 (1.00) | CNR2PPARAMEN1KMT2ACYP3A4 | |
| Beta-Caryophyllene SCHEMBL22607973 | 0.73 | CNR2 (1.00) | CNR2PPARAMEN1KMT2ACYP3A4 | |
| Beta-Caryophyllene SCHEMBL3505514 | 0.73 | CNR2 (1.00) | CNR2PPARAMEN1KMT2ACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230279560-A1 | CYCLIC COMPOUNDS AS AROMA CHEMICALS | BASF SE (DE) | 2023-09-07 | — | — | US | claimed |
| EP-4189141-A1 | CYCLIC COMPOUNDS AS AROMA CHEMICALS | BASF SE (DE) | 2023-06-07 | — | — | EP | claimed |
| CN-115943229-A | Cyclic compounds as aromachemicals | 巴斯夫欧洲公司 | 2023-04-07 | — | — | CN | claimed |
| US-20230279560-A1 | CYCLIC COMPOUNDS AS AROMA CHEMICALS | BASF SE (DE) | 2023-09-07 | — | — | US | disclosed |
| EP-4189141-A1 | CYCLIC COMPOUNDS AS AROMA CHEMICALS | BASF SE (DE) | 2023-06-07 | — | — | EP | disclosed |
| CN-115943229-A | Cyclic compounds as aromachemicals | 巴斯夫欧洲公司 | 2023-04-07 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230279560-A1 | CYCLIC COMPOUNDS AS AROMA CHEMICALS | C1S, VDAC2, VDAC3 | CNR2 64/4885PPARA 1037/4885MEN1 947/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.